APOE and hyperlipidemia: Since the db/db diabetic mice do not develop marked atherosclerosis lesions at the conditions and time period studied, we employed the STZ-induced diabetic ApoE KO mice, a well-established mouse model of accelerated atherosclerosis driven by combined hyperglycemia and hyperlipidemia that resembles human atherosclerotic lesions [31,32].